Myelodysplastic Syndrome
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: The study was excluded if any of the following criteria were met: 1. Patients diagnosed with CHIP; 2. Patients with other hematologic or non-hematologic tumors; 3. Combined with more serious cardiovascular and cerebrovascular, liver, kidney and other organic diseases and peripheral neuropathy; 4. Pregnant or lactating women; 5. Patients with mental illness who cannot cooperate with treatment; 6. Patients with Class A and Class B infectious diseases. 7. Patients with active hepatitis; 8. Patients who are participating in other clinical trials; 9. Patients with poor compliance.
Exclusion criteria
Exclusion criteria: The study was excluded if any of the following criteria were met: 1. Patients diagnosed with CHIP; 2. Patients with other hematologic or non-hematologic tumors; 3. Combined with more serious cardiovascular and cerebrovascular, liver, kidney and other organic diseases and peripheral neuropathy; 4. Pregnant or lactating women; 5. Patients with mental illness who cannot cooperate with treatment; 6. Patients with Class A and Class B infectious diseases. 7. Patients with active hepatitis; 8. Patients who are participating in other clinical trials; 9. Patients with poor compliance.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood routine;Blood cell production assay;Tumor-related indicators;Tumor Microenvironment Detection;Bone marrow biopsy; | — |
Secondary
| Measure | Time frame |
|---|---|
| Arsenic concentrations in blood;Urine routine;Fecal routine;Liver function;Kidney function;electrocardiogram; | — |
Countries
China
Contacts
Shanghai municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine